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Abstract
Mycobacterium tuberculosis is the etiological agent of the pulmonary disease
Tuberculosis. It affects more than one-third of the world’s population. During bacterial infections,
macrophages and other phagocytic cells of the immune system target and neutralize the causative
agent. Following phagocytic uptake of bacteria by the macrophages, the phagolysosomal
compartment produces reactive oxygen species (ROS) through the so-called respiratory burst to
control the infection. Recent work by several groups indicates that pathogenic M. tuberculosis can
survive phagocytic uptake by macrophages through inhibition of the respiratory burst. I have
cloned and expressed Rv0846c, a protein known to be a membrane-associated multi-copper
oxidase from M. tuberculosis (MmcO). I hypothesised that MmcO suppresses the production of
ROS and may thus contribute to the survival of the pathogen during phagocytosis. Purified MmcO
displayed a significant activity against the model substrate ABTS. Various amounts of active
MmcO were tested against the ROS production in THP-1 monocyte cell line. Streptolysin-O-
permeabilized THP-1 cells that were exposed to 500 ng of the purified MmcO protein displayed a
significant reduction in the level of induced ROS by phorbol 12-myristate 13-acetate (PMA). This
study indicates that the MmcO has a potential role as a virulence factor for M. tuberculosis.
Keywords: M. tuberculosis, Multi-copper oxidase, Reactive oxygen species, Phagocytosis.
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1Introduction
Mycobacterium tuberculosis as a public health threat
Mycobacterium tuberculosis (M. tuberculosis) is widely recognized as the etiological agent
of the pulmonary disease Tuberculosis in humans. M. tuberculosis belongs to the
Mycobacteriaceae family that consists of 150 species under a single genus being Mycobacterium
(Lory, 2014). It is possible for a species of Mycobacteriaceae to be present in water and soil, from
where they can establish their presence in animals and humans causing disease (Galagan, 2014;
Deffert, 2014). A number of species are pathogenic and slowly growing mycobacteria that have a
doubling time of 24h such as M. tuberculosis. Other species are non-pathogenic and fast-growing
mycobacteria which can multiply every 3-4 h including Mycobacterium smigmatis (Klann et al,
1998). Despite the fact that Mycobacteriaceae’s species are taxonomically different (pathogen and
non-pathogen), the main characteristics of the cell wall shared by all these species are almost
identical.
The Mycobacteriaceae family is catagorized as being acid-fast, aerobic, as well as non-
spore forming bacilli (Sakamoto, 2012). The outstanding trait of this family is the unique waxy
cell wall. The waxy cell wall contains lipids, peptidoglycan layers and hydrophobic mycolic acids,
which is anchored by arabinogalactan (Figure1) (Hett & Rubin, 2008). Mycolic acid is a wax
coating representing approximately 50% of the dry weight of the cell wall. This is what renders
the cell wall impermeable to a number of chemicals included in the gram stain (Kleinnijenhuis et
al, 2011). The only effective stain for Mycobacteriaceae is the Zhiel-Neelson stain, which is an
acid-fast pigmentation stain. Nevertheless, researchers have classified the Mycobacteriaceae
family members as Gram- positive organisms based on genetic similarities.
2Figure 1: The structure of the Mycobacterial waxy cell wall. This Figure demonstrates the
main components of the cell wall and their distribution. Above the cytoplasmic bilayer
membrane, the inner layer is comprised of peptidoglycan that links to arabinogalactan layer
covalently and lipoarabinomannan is elongated between both of them. The outer membrane is
made of mycolic acids, and outer lipids layer along with surface protein. This Figure is adapted
from http://faculty.ccbcmd.edu/courses/bio141/lecguide/unit1/prostruct/u1fig11.html
3Furthermore, the pathogenic members of this family are grouped under the Mycobacterium
Pathogen Complex (MPC) group (Forrellad et al, 2013; Lory, 2014). A number of species make
up the MPC that includes M. tuberculosis, Mycobacterium africanum, Mycobacterium bovis,
Mycobacterium canettii, Mycobacterium microti, Mycobacterium caprae and Mycobacterium
pinnipedii. Studies have demonstrated similarities among these species at the genomic level
(Forrellad et al, 2013). The M. tuberculosis genomic DNA, for example, has a 99.95% sequence
identical with the M. bovis DNA sequence (Sakamoto, 2012). Research has shown that M.
tuberculosis is characterized as a non-motile, non-sporulating acid-fast bacillus. Although M.
tuberculosis is classified as Gram-positive according to the genomic similarity (phylogenetic
analysis) and the thick peptidoglycan (PG) or murein layer (Sakamoto, 2012), it is structurally
related to Gram-negative bacteria. This similarity is a result of having similar cell wall
components, pseudo-periplasm, and pseudo-outer-membrane (Hett & Rubin, 2008; Fu & Fu-Liu,
2002). Therefore, classifying this bacterium as one of either Gram stains has not been determined.
M. tuberculosis requires an aerobic oxygenated environment in order to multiply. It multiplies in
a slow manner due to slow passing of nutrients through the cell wall. This feature makes it possible
for M. tuberculosis to develop and become resistant to recognition by the host immune system
(Kleinnijenhuis et al, 2011).
Epidemiological studies demonstrate that M. tuberculosis H37Rv is a prevalent virulent
strain that causes TB. Its genome is made up of 3,925 identified genes and ~250 genes out of this
total participate in fatty acid metabolism during the dormant period within the host cell (Cole et
al, 1998). In North America and Europe, major epidemics broke out during the 18th and the 19th
centuries but M. tuberculosis was identified as the etiological agent of TB in 1882 by Robert Koch
(Sakamoto, 2012; Comas et al, 2013). It was proposed, based on recent studies on the bacterium
4genome sequences, the emergence of M. tuberculosis took place in Africa approximately 70,000
years ago (Comas et al, 2013; Cambier et al, 2014). Since then M. tuberculosis bacilli have evolved
and been transmitted worldwide from one infected person to another causing TB infection (Daniel,
2006; Galagan, 2014). Data from the World Health Organisation (WHO) indicates that
approximately one-third of the global population is infected with M. tuberculosis and out of this
number, 1.5 million people lose their lives as a result of TB. In fact, it is estimated that 1 of 3
deaths in people who are HIV-positive are contributed to TB (WHO Tuberculosis Fact Sheet N104,
2016). The prevalence of TB varies by region: in the U.S.A, for example, there were 2.96 cases of
TB per 100 000 people in 2014. Among people migrating to the US, the rate of infection is higher,
by a factor of 13, compared to people who were born in the US (WHO Global Tuberculosis Report
2014).
Tuberculosis infection
M. tuberculosis can be described as an aerobic bacterium, which mostly affects the lungs.
Other parts of the body, such as the lymphatic and central nervous as well as the gastrointestinal
and circulatory systems can also be affected by M. tuberculosis (Dwivedi, 2011). M. tuberculosis
transmission occurs through the inhalation of aerosolized droplets coming from the coughing or
sneezing of an infected person. After inhalation, the pathogen is phagocytosed by the lung’s
alveolar macrophages (Shi & Darwin, 2015). In some cases, the pathogen can possibly escape the
macrophage’s phagocytosis process in order to multiply and disrupt the macrophage. This
disruption allows the pathogen to be ingested by blood-derived macrophages that were initially
recruited by the release of the chemokines. In this stage of infection, the blood- derived inactive
macrophages create an environment for the pathogen to start a logarithmic growth but not to
5eliminate it (Kleinnijenhuis et al, 2011). Approximately 2 to 3 weeks after infection has established
itself in the early lesions, the T lymphocytes multiply and the T helper (TH) cells signal for the
release of pro-inflammatory cytokines including interferon-γ (IFNγ) to activate macrophages and 
promote the destruction of the intracellular M. tuberculosis. Consequently, the intracellular growth
of the pathogen ceases and extracellular pathogen growth becomes restricted within the central
solid Caseous necrosis that is present in the early lesions or granulomas. The purpose of this
Caseous necrotic tissue in the granuloma is to control the pathogen spread and to protect the lungs
from becoming damaged (Kleinnijenhuis et al, 2011).
When an infection remains dormant within a granuloma, it is referred to as a latent TB
infection. It may take months or years before reactivation can take place, or reactivation may even
fail to take place in an individual with a healthy immune system. The reactivation of the bacterium
generally occurs under a failure in immune surveillance. This can occur when the host is exposed
to co-infections with HIV or with certain factors like old age, or during treatment with medications
that result in an immunosuppressive state (Smith, 2003; Boshoff & Barry, 2005; Verver et al,
2005). Latent TB can then become reactive and is known as active TB. Active TB leads to death
only if the patients with immune system failure are suffering from other diseases including
malignancy, liver cirrhosis, renal failure, and pneumonia (Lin et al, 2014). The weakness of the
body’s immune system promotes M. tuberculosis to multiply and attack the lung or other parts of
the body via the bloodstream. In another word, the M. tuberculosis defeats the immune system
responses. Patients with active TB are more likely to die due to Septic shock as well (Lin et al,
2014). TB also is considered as a cause of respiratory failure called acute respiratory distress
syndrome (ARDS). ARDS leads to death when the lung inflammation, hypoxemia and frequently
multiple organ failures are caused by the reduction in gas exchange and the systemic release of
6inflammatory mediators (Raina et al, 2013). Other than the disease, active TB can lead to death in
cooperation with environmental factors, such as poverty and unhealthy diet (WHO Fact sheet
N°104, 2016). As a result, TB leads to death only in the presence of cofactor diseases or
environmental influence.
So far, only one vaccine has been approved to prevent TB infection and is known as the
Bacille Calmette-Guérin (BCG) vaccine. BCG is an attenuated strain of M. bovis and since M.
bovis causes TB in cattle and shares a 99.95% sequence similarity with the M. tuberculosis DNA
sequence (Sakamoto, 2012), the genomic similarity makes it the perfect vaccine against human
TB. However, it is effective in children, but not adults (Niki et al, 2015; WHO, 2015). This leaves
antibiotics to be the only option for the treatment of TB infections. Active TB patients have both
systemic and lower respiratory track symptoms including fever, night sweat, weight loss, vomiting,
coughing up blood, chest pain, and belaboured breathing. Any patient in this situation requires
intensive therapeutic treatment (CDC:Tuberculosis (TB) Disease: symptoms & Risk Factors,
2016).
Treatment of active Tuberculosis
To many scientists, the treatment of this disease has become a global challenge in their
attempt to prevent disability and death, as well as in halting the spread of the disease. Several
effective drugs have been developed over the years for treating patients suffering from active TB
infection. TB drugs, unlike those for many other infectious diseases, are given for a long period of
time. Additionally, the use of a single antibiotic for the treatment of TB infection is proving to be
ineffective. Streptomycin, the first successful antibiotic to be used against TB, provided the first
case in the history of resistance to a drug during the treatment for TB infections, in 1940s
7(Keshavjee & Farmer, 2012). In 1943, Salvador Luria and Max Delbruck came up with a
demonstration to prove that random genetic mutation occurred even when there was no selection
pressure by antibiotics (Murray, 2016). Thus, it became important to note that resistance to the
drugs always developed when a signal drug was used for treatment but the resistance was much
lower when a combination of at least two drugs were used for treatment (Keshavjee & Farmer,
2012). It was also believed, M. tuberculosis morphology also contributed to drug resistance in that
it has a waxy cell wall, which enhances resistance to antibiotics, acidity, and alkalinity (Daffe &
Draper, 1998).
Current treatment for TB requires a multiple drug regimen. Upon confirmation of disease,
a combination of up to four antibiotics, known as RIPE, are used as the initial course of drug
treatment. These drugs are rifampin (RIF), isoniazid (INH), pyrazinamide (PZA), and ethambutol
(EMB). The course of intensive treatment is strictly for a period of two months to ensure that the
pathogen is completely eradicated. The patient can then be placed on a less aggressive treatment
with only RIF and INH for an additional 4 months (CDC “Treatment for TB Disease”, 2016). As
a result of patients missing doses or stop to complete the treatment courses, M. tuberculosis
increases its immune resistance and expresses enzymes. These enzymes combat the action of the
available drugs (Forrellad et al, 2013), and lead to the development of the multidrug resistance
strains. That means the therapy frequently will last from six months to two years to minimise
resistance. However, the WHO data showed that the multidrug resistance strains of M. tuberculosis
have emerged from 3.3% of new cases and up to 20% of treated cases as a side effect of prolonged
antibiotic therapy (WHO Global Tuberculosis Report 2015). M. tuberculosis has developed
multidrug resistance strains. Therefore, a comprehensive understanding and characterizing the
8interaction between the immune system of the host and the pathogen would lead to new therapeutic
strategies.
Pathogen-host interactions in TB
M. tuberculosis can develop resistance to the immune system of the host in addition to
treatment strategies, which has made its eradication difficult. Despite the fact that no classical
virulence factors such as toxins are existed in M. tuberculosis (Forrellad et al, 2013), M.
tuberculosis can effectively cause infection and survive within the host for a very long period
(Sakamot, 2012). Thus, M. tuberculosis is unique as compared to other microorganisms, because
its persistence inside the host is due to its transmission cycle and its ability to compromise the
human immune system (Prozorov et al, 2014; Cambier et al, 2014).
During pathogenic infections (non-TB), the immune system recognises the bacteria as
invading pathogen. Activation of the innate immune system involves the process called
phagocytosis by the macrophages or neutrophils. The phagocytosis process starts by an engulfing
stage, when the macrophages are activated by the pathogen through stimulation of the Pattern
Recognition Receptors (PRRs) such as cytokines IFN- γ, Toll-like receptor 2 (TLR2), or other
phagocytic receptors (Weiss & Schaible, 2015). After that, the engulfing stage of the pathogen into
a phagosomal vacuole within the macrophages, where the pH is about 6.4. This stage forms the
early phagosome and leads to the production of more anti-microbial reactions (Weiss & Schaible,
2015; Tan & Russell, 2015). The early phagosome stage is marked by small GTPase markers
including Rab5A (Weiss & Schaible, 2015). Then the maturation stage is when the membrane of
the phagosome fuses with the lysosome in the presence of phosphatidylinositol 3-phosphate
(PI3P), and generating the phagolysosome. PI3P is a phospholipid found in cell membranes as it
9is synthesized by a phosphatidylinositide 3 kinase (Weiss & Schaible, 2015). The phagolysosome
stage is marked by the interchange between Rab7A and Rab5A on the phagolysosome membrane
(Weiss & Schaible, 2015). This stage introduces the slow reduction of the pH inside the
phagolysosome compartment by activation of the ATP-dependent proton pumps (Sturqill-
Koszycki et al, 1994; Deffert et al, 2014) to destroy the pathogen through acidification (pH 4.5).
The acidification results in the activation of the hydrolytic enzymes (Figure 2) (Deffert et al, 2014)
and the stimulation of the NADPH oxidase to generate Reactive Oxygen Species (ROS), which
consequently causes the respiratory burst against the pathogen. Although phagocytosis is an
effective process to eradicate most pathogens, there are several pathogens like Listeria and
Shigella that escape the phagocytosis process and reproduce in the cytoplasm (Smith, 2003). Other
bacteria, like Salmonella typhimurium, not only can survive the phagocytosis process but also
require the acidic environment of the macrophage phagolysosome such as pH 4.6 in order to
survive (Rathman et al, 1996).
It is a different case when it comes to M. tuberculosis infection. M. tuberculosis has a more
complex cycle in the macrophage and requires blocking of phagosomal maturation, lysosome
fusion, and the prevention of acidification of the phagosome environment which allows the
pathogen to escape destruction and live in macrophages. Similar to all pathogenic infection, the
host innate immune system recognises the M. tuberculosis via different receptors. These different
receptors of macrophage interact with M. tuberculosis to generate various responses (Figure 2).
M. tuberculosis interacts with TLR2 by pathogen-components like phosphatidylinositol
mannosidase (PIMs) and lipoarabinomannan (LAM) on its surface and promotes inflammation
(Sakamoto, 2012). M. tuberculosis has the ability to utilise some of the macrophage receptors for
its benefit, for example, M. tuberculosis engages to the mannose receptor (MR) or complement
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receptor 3(CR3) to evade the respiratory burst and phagosome maturation (Armstrong & Hart,
1975; Kang et al, 2005). After the pathogen recognition step, the macrophage phagocytosis process
stops at the early phagosome where the M. tuberculosis is able to resist and slowly proliferate.
This happens due to the M. tuberculosis ability to adapt to the harsh condition of the host
environment and to defend its self from the antibacterial action of the phagosome. M. tuberculosis
adaptation strategy is ascribed to its fatty acids usage as a substitute metabolic component for
glucose. This leads to thickening its cell wall and making it impermeable. In addition to the M.
tuberculosis’s ability to adapt to the environment of the host cells, M. tuberculosis virulence
factors is essential for its defence strategies. Firstly, Lipids in the form of Phthiocerol
Dimycocerosate (PDIM) protect the cell wall from detection by macrophages PRRs. Research has
shown that lipid phosphatase production and secreted acid phosphatase SapM, through PI3P
hydrolysis, prevent the fusion of the phagosome with the lysosome. M. tuberculosis contains
surface lipids and LAM, as well as cord factor which impedes vesicle fusion (Pethe et al, 2004).
Secondly, Tryptophan Aspartate Coat Protein (TACO) constraints phagosome-lysosome fusion
through the activation of calcium-dependent phosphatase calcineurin (Figure 2) (Sakamoto, 2012;
Weiss & Schaible, 2015). Finally, the degradation of the pathogen by macrophages through
phagosome acidification is prevented by M. tuberculosis induced depletion of the level of the
phagosome proton-ATPase making the acidification ineffective and resulting in M. tuberculosis
survival at a pH of approximately 6.5 (Sturqill-Koszycki et al, 1994; Weiss & Schaible, 2015).
Remarkably, the interaction of M. tuberculosis with lipid compartment bodies or droplets of lipid
within the macrophage ensures a continuous source of nutrient for M. tuberculosis. The whole
process of M. tuberculosis phagocytosis can be characterized as an early phagosome stage
associated with Rab5A (Weiss & Schaible, 2015).
11
Figure 2: Phagocytosis in macrophages: the Figure shows the internalization and degradation
of microbes under normal condition and in case of the infection with M. tuberculosis where the
maturation processes are interrupted. The Figure is adapted from (Kaufmann, 2001).
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Mechanisms for elimination and control of the pathogen by phagocytic cells –
Respiratory Burst
To eliminate and control the threat of pathogens, host cells employ a variety of mechanisms
including granuloma formation, phagolysosome fusion and even apoptosis to prevent pathogen
replication. However, the macrophages’ antimicrobial activity is largely defined by respiratory or
oxidative bursts. The respiratory burst (RB) describes the process when reactive oxygen species
(ROS) are rapidly released to terminate the targeted bacteria (Seres et al, 2000; Smith, 2003). ROS
can be generated by the activation of Nicotinamide Adenine Dinucleotide Phosphate Oxidase
(NADPH) during the last stages of phagocytosis. NADPH oxidase is a membrane-associated
enzyme that is composed of five subunits which are NOX2 (gp91phox), p67phox, p22phox,
p40phox, and p47phox. The key electron transporter is Gp91phox (Figure 3).
The RB starts when the NADPH subunits assemble into a complex that is enzymatically
active causing the reduction of the O2 molecule into superoxide anions (O2-). The resulting
electrons from the reduction reaction are transported through the cytochrome b to the oxygen
molecules contained in the phagosome. Cytochrome b is a constitutive membrane protein present
in phagosomes as well as the plasma membrane (Berton et al, 1986; Dahlgren & Karlsson,1999;
Cross & Segal, 2004). The superoxide anions then dismutase into hydrogen peroxide (H2O2).
Finally, H2O2 can combine with Cl− in the presence of myeloperoxidase to produce Hypochlorous
acid (Figure 4) (Kettle & Winterbourn, 1990) or can reduce copper or iron ions, resulting in
hydroxyl radical (OH•) production. The cellular damage that includes damaged DNA and
oxidation of lipid/protein is caused by Hypochlorous acid and hydroxyl radicals and eventually
result in the destruction of the bacteria (Figure 4) (Kettle & Winterbourn, 1990; Poyart et al, 2001).
The interaction of H2O2 with nitric radicals, to produce peroxynitrite (ONOO-) and also contributes
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to pathogen destruction (Ehrt & Schnappinger, 2009). ROS, besides being part of antimicrobial
activities, plays a part in regulating cellular responses including apoptosis, cytokine release, and
cell proliferation.
In spite of these effective anti-microbial activities, M. tuberculosis has adapted to grow
inside macrophages. M. tuberculosis DNA is protected from oxidation by the use of histone-like
proteins (LSR2) as a physical barrier and the presence of the UvrB endonuclease enzyme that
works in repairing mycobacterial DNA (Saviola, 2013). The repair of M. tuberculosis oxidized
proteins is handled through the activity of methionine sulfoxide reductase (Mst) (Deffert et al,
2014). M. tuberculosis also produces some enzymes that detoxify ROS (Ehrt & Schnappinger,
2009). Such as two superoxide dismutases (SodC and SodA), a catalase-peroxidase (KatG),
mycothiol, NADH-dependent peroxidase, and peroxynitrite reductase (Deffert et al, 2014).
Superoxide dismutase (SOD) is known for being a dynamic superoxide radical scavenger that can
interfere with the production of ROS through the conversion of toxic superoxide to oxygen
molecules and hydrogen peroxide (Liao et al, 2013). The study undertaken by Liao and his
colleagues showed that purified SodA and SodC can inhibit respiratory burst free radical
production (Liao et al, 2013). In addition, the hydrogen peroxide radical is converted into water
by Catalase-peroxidase (KatG) (Ng et al, 2004; Mo et al, 2004). Since M. tuberculosis possesses
the rv0846c gene that codes for the multi-copper oxidase (MmcO) with oxidoreductase ability, M.
tuberculosis MmcO is a considerable candidate to inhibit reactive oxygen species (ROS)
generation.
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Figure 3: NADPH oxidase complex: the Figure represents the five subunits of NADPH complex, tow
transmembrane units’ gp91 and p22 that catalyze the transfer of electrons from cytosolic NADPH to
molecular oxygen in order to generate the superoxide. The other subunits p47, p40, p67 work as regulator
along with small GTPase Rac. This Figure is adapted from
https://www.researchgate.net/Figure/257075489_fig1_NADPH-oxidase-structure-NADPH-oxidase-is-a-
multi-subunit-enzyme-complex-present-in-the
Figure 4: Macrophage respiratory burst: the Figure illustrates the process by which
the macrophage NADPH oxidase generating the ROS to eradicate the pathogenic bacteria.
This Figure is adapted from http://www.clinsci.org/content/111/1/1
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Copper
Copper is an essential component and a functional co-factor for the MmcO enzyme. It also
has been proven to be an essential cofactor for a range of enzymes including amine oxidases, which
play a part in the generation of neurotransmitters; methane monooxygenases used by
methanotrophs in the generation of energy; and SOD responsible for protecting cells against
oxidative stress (Balasubramanian & Rosenzweig, 2007; Grass et al, 2011; Linder & Hazegh-
Azam, 1996; Pena et al, 1999). At least two enzymes present in M. tuberculosis are known to
require copper in their activities. Cytochrome c oxidase, which is the first enzyme, require copper
as the terminal electron acceptor for aerobic growth (Shi et al, 2005). The second enzyme is
superoxide dismutase (SodC) which copper and zinc are essential minerals for its activity to inhibit
the oxidative burst of host macrophages (Piddington et al, 2001). Not only does cooper work as a
co-factor for a number of enzymes, it also has roles in the energy generation and in the reduction
of oxidative radical which make it an important element for cellular viability. In general, copper’s
importance to organisms is a result of its redox potential (Pena et al, 1999). In biological systems,
copper possesses the ability to cycle between the toxic Cu1 and less toxic Cu2 states (Crichton &
Pierre, 2001).
Copper Toxicity
In the innate immune response, copper is essential. Studies have demonstrated that
mobilisation of essential metals like copper is a macrophages’ way of increasing bactericidal
activities. Macrophages increase the copper’s toxicity in the phagosomal compartment by the
accumulation of copper (Wagner et al, 2005) to promote the killing of bacteria. The respective rise
in cellular copper and phagosomal copper are mediated by the copper transporters CTR1 and
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ATP7A. Normally, when macrophages are exposed to lipopolysaccharide or interferon-γ 
activation, they increase the expression of both atp7a and ctr1 (White et al, 2009). However,
bacteria utilise different methods to fight against the high level of copper toxicity, by reducing the
ATP7A protein levels to survive the copper presence within the phagosome (Wagner et al, 2005;
White et al, 2009). As a result, there must be maintenance of the correct balance of copper needed
as co-factor function while damage resulting from highly redox active metal is minimised.
MmcO, which consists four copper atoms, is initially introduced as a copper resistant
enzyme for many identified bacteria including Pseudomonas syringae (Cha & Cooksey, 1991),
Salmonella enterica (Achard et al, 2010), and Escherichia coli (Grass & Rensing, 2001). Several
MmcOs have been found in other organisms, like fungi and other bacteria, together with human
ceruloplasmin and plant ascorbate oxidase (Solomon et al, 1996; Quintanar et al, 2007).
Interestingly, the structural morphology is almost similar in all discovered MmcOs. The
involvement of bacterial MmcOs in copper resistance is through the detoxification of toxic copper
Cu1 to less toxic Cu2 within the host’s cells. Also, MmcO is needed for the purposes of virulence
in bacteria like Xanthomonas campertris (Hsiao et al, 2011) and Salmonella (Achard et al, 2010).
Research has demonstrated that the M. tuberculosis susceptibility to macrophage toxic copper has
been increased by the knockout of M. tuberculosis’ MmcO at least 10-fold; therefore, M.
tuberculosis employs copper toxicity resistance which is facilitated by MmcO (Rowland &
Niederweis, 2013). To sum up, MmcO has oxidative ability to block the copper toxicity by
detoxification Cu1, this property could also employ the neutralizing/suppression of the ROS during
respiratory burst since there is no study has been conducted yet on this concept.
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Multi-Copper Oxidase (MmcO)
MmcO is a membrane-associated protein of M. tuberculosis with oxidoreductase activity.
The rv0846c gene codes for MmcO, a 54 kDa protein that contains 504 amino acids. The rv0846c
gene is well conserved among pathogenic mycobacteria but remarkably absent from non-
pathogenic species which could be an initial indication that it plays an essential role in M.
tuberculosis survival (Cha & Cooksey, 1991). It contains a N-terminal signal sequence typical of
prokaryotes within the first 38 amino acids (Rowland & Nieoderweis, 2013). Previous studies
indicated that the M. tuberculosis’ MmcO signal peptide can lead to localization of MmcO to the
pseudo periplasmic space, similar to many other bacterial multi-copper oxidases such as
Pseudomonas syringae CopA, and C. jejuni MmcOC. MmcO has a wide range of organic
substrates like Fe (II) and phenolic compounds (Rowland & Nieoderweis, 2013). MmcO oxidation
results in a single-electron that combines with oxygen to be reduced to water. This demonstrates
that MmcO activities need oxygen. MmcO has a total of four copper ions which are coordinated
in central sites: these are Type 1 copper (Cu1); Type 2 (Cu2) and a pair of type 3 (Cu3) copper.
Since MmcO substrate oxidation takes place at Cu1, Cu1 is the mononuclear center that
coordinates with cysteine to make MmcO blue in color. The electrons resulting from this oxidation
reaction are transferred to the trinuclear center comprising Cu2 and the pair of Cu3 where the
reduction of oxygen to water takes place (Figure 5) (Quintanar et al., 2007). M. tuberculosis’
MmcO has proven to be a virulence factor against host copper toxicity; nonetheless, studies on the
role of MmcO in the respiratory burst are limited or non-existent, which is what this study is
focused on.
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(B)
Figure 5: Multi copper oxidase structure: (A) The three dimensional structure of
MmcO (adapted from Phyre2 program) and the Figure also shows the active site with
the determination of the oxidation center (Cu1) and reduction center (Cu2 and pair of
Cu3). (B) Schematic of the MmcO’ catalytic mechanism; which the single-electron
oxidation of a substrate and the subsequence reduction of oxygen molecule into water.
(A)
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Rationale
M. tuberculosis is a pathogenic bacterium causing severe TB disease that kills
approximately 1.5 people annually. New aspects to the pathogenicity of M. tuberculosis continue
to be discovered. Studies indicated that M. tuberculosis strains became drug resistant to single
drugs but the combination of at least two drugs or more shows greater efficacy. However, M.
tuberculosis has evolved to develop multidrug resistance strains over time. It is known that M.
tuberculosis cell wall components and the secretion enzyme system are crucial defensive
mechanisms against the host innate immune system including macrophages in which antimicrobial
activity is defined by the respiratory burst. In this case, understanding the role of different virulence
factors in its pathogenicity could lead to better therapeutic strategies. M. tuberculosis Multi Copper
Oxidase (MmcO) is considered as a virulence factor. A recent study has indicated MmcO as a
virulence factor in resistance to copper toxicity but the role of MmcO in response to macrophage
respiratory burst requires more work (Rowland & Nieoderweis, 2013). MmcO contains copper,
and copper type 2 (Cu2) has proven its ability to neutralize and reduce superoxide (O2•−) into
oxygen (Gaetke & Chow, 2003). This makes the MmcO a good candidate to suppress/ prevent the
release of ROS. In addition, MmcO possesses the capability of consuming and reducing oxygen
molecules to water (Heppner et al, 2014). O2 molecules are required in ROS-production as well as
MmcO activity, leading to the possibility of MmcO competing with NADPH oxidase for O2.
Therefore, we will investigate if MmcO plays a role in the inhibition of the phagocytic respiratory
burst in THP-1 cell line. THP-1 is defined as a human monocytic cell line module, which was
obtained from a one year old male patient suffering from acute monocytic leukemia (Adati et al,
2009). We hypothesised that MmcO has the capability of interfering with ROS formation during
the phagocytic respiratory burst and this contributes to the survival of M. tuberculosis.
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Objectives
The main research objective of this study is to characterize the M. tuberculosis multi-
copper oxidase’s potential role in interfering with the formation of ROS by using the THP-I
monocyte cell line with biochemical assays and proteomics methods. The specific objectives are:
1. The cloning of M. tuberculosis rv0846c gene in pET21-a vector
2. The expression of protein in E.coli BL21.
3. The purification of recombinant MmcO.
4. The study of MmcO involvement in interfering with the production of ROS in the THP-1 cells.
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MATERIAL & METHODS
Cloning of the M. tuberculosis multi-copper oxidase
The sequence of the multi-copper oxidase (rv0846c) gene from H37Rv strain was obtained
from Tuberculist 2.6 database [http://tuberculist.epfl.ch/quicksearch.php?gene+name=Rvo846c]
and National Center for Biotechnology Information (NCBI) website
[http://www.ncbi.nlm.nih.gov/gene/?term=Rv0846c]. The primers that were used to amplify the
Rv0846c gene were designed by Primer-BLAST [http://www.ncbi.nlm.nih.gov/tools/primer-
blast/]. The Forward primer (FP) is [5’ AATAATGATCTCATGCCCGAGCTGGCCACG 3’] and
the Revers primer (RP) is [5’
AATAATCGCCGGCGCGGCGGCGGCGGCCCCAGAATGTAGTCCAG 3’]. Both of these
primers contain restriction sites (red), overhang nucleotides (bolded black), and a linker (green).
The primers were synthesised by Invitrogen Life Technologies. The rv0846c gene was designed
as a fusion construct with a 6xHis tag at the C-terminus by a glycine linker (Figure 6A). A linker
consisting of 9 glycines, 4 were created by the reverse primer and 5 were part of the pET21a vector,
was used. The amplification of rv0846c was carried out using a polymerase chain reaction (PCR),
Q5 High fidelity polymerase kit, and the pair of primers. The composition of each 25 µl of reaction
was as follow: 1X Taq buffer, 25 mM MgCl2, 100 µM dNTP, 20 nM forward and reverse primers,
2.5% DMSO, 50 ng DNA and 1unit Q5 High fidelity Taq polymerase [New England Biolabs
(NEB)]. M. tuberculosis H37Rv strain genomic DNA, which was used as template in this study,
was synthesised by GenScript Company. The PCR reaction begins with a denaturing step for 5
min at 95°C, followed by 35 cycles at 94°C (for1 min) and at 62°C (for 40 s) [which is the optimal
annealing temperature based on NEB calculator and our optimization], and an extension period for
1.30 min at 62°C followed by a 10 min extension at 72°C. The PCR products were examined by
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electrophoresis as a conformational step. A sample of 5 µl from each reaction was subjected to
electrophoresis on 1% agarose gels containing 0.5 µg/ml ethidium bromide. Samples were loaded
with 6X loading dye [Fermentas] and they were run in 1X TAE running buffer [Promega] for one
hour at a constant voltage of 100 V. The gels were visualized using a UV trans illuminator
[chemidoc xrs Bio-RAD]. The PCR product was then cloned into a bacterial expression plasmid
known as pET21a [GenScript] (Figure 6B). Both PCR product and pET21a plasmid were subjected
to double digestion by two different restriction enzymes (NdeI and NotI) [NEB]. Both were treated
separately with 1µl of each restriction endonuclease (NotI (10 U/µl) and NdeI (10 U/µl)) that
mixed with 2µl of 10x Digestion buffer [Fermentas] in a total reaction volume of 20 µl. The
mixture was incubated at 37°C for 2 h followed by heat inactivation at 80°C for 10 min. The MmcO
and the pET21a vector were mixed with T4 DNA ligase [NEB] in a total volume of 15 µl at a ratio
of 1:3 (plasmid to insert respectively) after they were cleaned up using EZ-10 spin DNA clean up
columns [Bio Basic Inc]. The ligation reaction was kept at room temperature (RT) for 30 min then
placed at 4°C overnight.
Transformation of Escherichia coli BL21
BL21 strain of E. coli was cultured in Luria Bertani (LB) [Fisher Scientific] antibiotic-free
media and incubated in a rotary shaking incubation [Forma Scientific] at 37°C/250 rpm for 12 h.
The bacterial pellets were resuspended in 0.1 M CaCl2 [Sigma] and then the mixture was incubated
for 1 h. At the end of the incubation period, the cells were centrifuged and the pellet resuspended
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Figure 6: pET21-a plasmid construct: (A) shows the Rv0846c gene design containing
N-terminal Rv0846c gene followed by Linker and C-terminal His-tag. (B) represents the
pET21a vector construct and the cloning site between (NdeI and NotI) restriction sites. (C)
indicates the His-tag location on the plasmid. This Figure is adapted from
https://www.addgene.org/20377/.
C
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in 0.1 M cold CaCl2 to the final volume of 1 ml. The cells, perceived to be competent, were placed
on ice ready for transformation. The BL21 strain of E.coli is commonly used as an expression host
for proteins. The transformation was performed following NEB manufacturer’s instructions with
some modification. 200 µl of BL21 competent cells were mixed with 2 µl≃ (10 ng) of the ligation
reaction mixture in a 1.5 ml micro-centrifuge tube. The sample was flicked gently and incubated
on ice for 30 min. The bacteria were then heat-shocked at 42°C for 90 s under different conditions
as follows: in a water bath for 40 s, and then immediately in a hot plate for about 50 s. Finally, the
sample was placed on ice for a further 5 min. For recuperation, 800 µl of sterile, antibiotic-free
SOC media (2% tryptone (w/v), 0.5% yeast extract (w/v), 10 mM NaCl, 2.5 mM KCl, 10 mM
MgCl2, and 20 mM glucose) [all components were from Fisher Scientific] was added and the
sample was incubated on an incubator-shaker [Forma Scientific] for 45 min at 37°C and 250 rpm.
Individual colonies were isolated by plating 100 µl of the sample on a selective LB agar plate
(2.5% LB broth, 1.5% agar [Fisher Scientific]) supplemented with 100 µg/ml ampicillin
[ThermoFisher Sci.] and incubated for 12 hours at 37°C.
Protein expression, inclusion bodies extraction and MmcO refolding
The transformed bacteria was cultured in 5 ml LB media supplemented with 100 µg/ml
ampicillin at 37°C/250 rpm for 12 h. 600 µl of this culture was added to 1 L LB media and grown
at 37°C in a rotary shaking incubator at 250 rpm until the optical density (OD600) of the culture
was 0.5-0.8 (about 2 h). Then 0.4 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) [Sigma] was
added and the culture was grown for a further 6 h at 35°C/250 rpm. At the end of the 6 h, the
culture was ready for protein extraction. The extraction of the recombinant protein from inclusion
bodies was performed in a similar way to experiments conducted by Rudolph and Lilie in (1996).
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In brief, the culture was centrifuged to obtain a cell pellet at 4°C/14,000 xg [Avanti J-52I
centrifuge, Beckman Coulter] for 20 min. The cell pellet was resuspended in 20 ml Lysis buffer
containing 50 mM Tris-HCl pH 8.00 [Fisher Scientific], 25 mM NaCl [Fisher Scientific], 5 mM
EDTA [Bio Basic], and 1% Triton X-100 [Sigma] (v/v), per gram wet weight of cell pellet. The
suspension was incubated on ice for 30 min and then sonicated for 10 s for 5 cycles at 16 V using
a Heat Systems-UltraSonic.inc, W208 Sonicator with 30 s rest on ice in between. The reason for
the ice resting time is to protect the extracted proteins from thermal degradation. Sonication
prevented clumping of the cells before centrifugation at 4800 xg [Eppendorf Centrifuge 5804 R,
Brinkman Instruments. Inc] and 4°C for 35 min. Next, the sample was washed to eliminate all the
indigenise protein of the host cell. The washing step was performed three times using 20 ml of
buffer A, B, and C. The first wash was done in buffer A (50mM Tris, pH7.5, 50mM NaCl, 50mM
EDTA, and 1%Triton). The second wash was performed in buffer B (50mM Tris, pH7.5, 1M NaCl,
50mM EDTA, and 1%Triton). The last wash was done in buffer C (50mM Tris, pH7.5, 50mM
NaCl, 50mM EDTA). The pellets were then resuspended in 10 ml solubilisation buffer which
included 8 M Urea [Fisher Scientific], 1 mM phenylmethane sulfonyl fluoride (PMSF) (v/v), 50
mM Tris-HCl pH 7.5, and 5 mM dithiothreitol (DTT) [Sigma] and incubated to disrupt the pellets
inclusion by additional shaking of the solution for 12 hours at RT.
To promote protein refolding, the solubilised sample was centrifuged at 4°C and 4800 xg
for 35 minutes, and then the 10 ml supernatant was transferred to dialysis tube, and subjected to
dialysis in 500 ml 10 mM Tris-HCl pH 7.4. This technique was used to gradually remove the
denaturant Urea so as to refold the denatured proteins. The dialysis was performed at the RT by
placing the dialysed beaker on the stirrer plate and changing the 500 ml dialysis buffer 3 times
with an interval of two hours. The last change of dialysing buffer was 1 L for a period of 12 h.
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Finally, the dialysate was subjected to centrifuge at 4°C and 12,000 xg for 5 min to isolate the
refolded protein in the pellet.
Protein purification using nickel affinity chromatography
The purification of the recombinant His-tagged MmcO protein was carried out using a 1
ml Nickel column (Ni) [GE Healthcare Life Science] according to the GE Healthcare Life Science
manufacturer’s instructions. In brief, the purification was carried out in two steps. First, the
refolded protein was first desalted on 26/10 desalting column [GE Healthcare Life Science] and
eluted with 20 mM NaSO4, 0.5 M NaCl, and 25 mM Imidazole v/v, which is the Nickel column’
binding buffer. Second, the 1 ml Nickel column was conditioned with 20 ml of the binding buffer
and then the desalted sample was applied at a flow rate of 1 ml /min (saved as the flow through
fraction) and the column washed with 20 column volume of binding buffer. The bound protein
was eluted in 10 column volume of elution buffer (20 mM NaP “nickel resin”, 0.5 M NaCl₂, and
500 mM Imidazole) and concentrated using an Amicon spin unit/Nitrogen with 10 kDa cut off
cellulose membrane and equilibrated with 10 mMTris-HCl (pH 7.4). The protein concentration
was measured using the Bradford Protein Assay Kit [Bio-Basic] with bovine serum albumin as the
standard (according to manufacturer instructions). This is a colorimetric assay that measures the
protein concentration based on the Coomassie Brilliant Blue dye-binding method. Protein solution
was prepared in duplicate and the intensity detected at 595 nm on a MRX Microplate Reader.
Protein concentrations were determined from the standard curve.
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Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
Denaturing SDS-PAGE gels were prepared as described by Hames (1998). In brief, SDS-
PAGE gels consisted of a 10% separating gel (2.5 ml 40% polyacrylamide, 2.5 ml 1.5 M Tris-HCl,
pH 8.8, 100 µl 10% ammonium persulfate, 100 µl 10% SDS, and 4 µl tetramethylethylenediamine
(TEMED) (v/v)) and a 5% stacking gel (500 µl 40% polyacrylamide, 500 µl 1 M Tris-HCl pH 6.8,
40 µl 10% ammonium persulfate, 40 µl 10% SDS, and 4 µl TEMED (v/v)). Once the gel
completely polymerized, the protein samples (5-40 µg) were combined with 4X Laemmli sample
buffer (44.4% glycerol, 4.4% SDS 0.1 M Tris-HCl pH 6.8, 0.02% bromophenol blue w/v, and 10%
β-mercaptoethanol v/v), boiled at 95°C for 5 minutes, and then loaded into the wells. The gels
subjected to electrophoresis for 45 min at a constant voltage of 100 V using a Mini-PROTEAN
Tetra System [BIO-RAD] with 1X SDS running buffer (144 g glycine [Sigma], 1/10 dilution of
30 g Tris-HCl, pH 8.3,10 g SDS in 1 L). The gel was stained with Coomassie brilliant blue R-250
(methanol, acetic acid) stain for visually documentation.
Western blot
The western blot was performed as described by Mahmood & Yang (2012) with some
modifications. In brief, the proteins were transferred to a 0.22 µm PVDF membrane [GE
Healthcare Life Science] rinsed in 100% methanol. The PVDF membrane and 10% SDS-PAGE
were sandwiched between two thick blot pads previously soaked in 1X transfer buffer (30.2 g/L
Tris-HCl, pH 8.3 and 144 g/L glycine [Sigma]) and the protein transferred using a semi-dry
apparatus [Bio-Rad Trans-blot] at constant voltage (15 V) for 35 min. After transferring, the
membrane was blocked by incubation in blocking solution (5% skim milk in 1X PBST buffer
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contains 8 g/L NaCl, 0.2 g/L KCl, 1.44 g/L Na2HPO4, 0.24 g/L KH2PO4 and 0.05% Tween-20) at
4°C with shaking for 12 h. This membrane was rinsed 3 times in 1 X PBST and then probed by
incubation with the primary anti-His-tag antibody [Gen Script] at a 1/3000 dilution in 5% milk in
1 X PBST at RT with shaking for 2 h. The membrane was washed 3 times in 1 X PBST and then
probed with the secondary, anti-rabbit IgG alkaline phosphatase conjugated antibody [Biomeda]
at 1/30000 dilution at RT with shaking for 2 h. For the last time, the blot was washed three times
for 5 min with 1 X PBST and once with 1X PBS followed by the detection of the bond attached
using 0.8 mg 5-bromo-4-chloro-3-indolyl phosphate (BCIP) and 1.2 mg nitro blue tetrazolium
(NBT) in 10 ml of detection buffer (1MTris-HCl pH 9.6, 1M MgCl2). After the desired band
appeared, the membrane was left to dry and the visually appearance of the targeted band
documented.
MmcO activity measurements
The MmcO activity assay is based on oxidizing the ABTS (2,2'-azino-bis-3-
ethylbenzthiazoline-6-sulphonic acid) substrate [Sigma-Aldrich] to the ABTS• radical to generate
a green-blue color by the action of MmcO protein. This assay was performed as described
previously with modification (Grass & Rensing, 2001). In brief, the assay was carried out using a
Costar 96-well flat bottom plates and a volume of 200 µl. 20 µg (equivalent to 0.327 nmol) of
MmcO protein was added to 50 mM Sodium acetate [Sigma] buffer, pH 4 containing 2 mM ABTS
and 2 mM CuSO4 [Sigma]. The plate was sealed and incubated at RT with shaking for 4 h. The
activity readings were taken every 30 min for 4 h. Finally, the absorbance of the ABTS formed
was measured at 405 nm using a MRX Microplate Reader. Specific activity was calculated using
A= ɛlc where A= absorbance, ɛ = 18,400 M-1 cm-1 ,1 = 0.58cm, and c= concentration of the
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solution. One unit of enzyme activity is defined as the amount of enzyme required to oxidize 1
µmol ABTS in 1 min.
Delivering MmcO into THP-1 cells
The THP-1cell line was generously provided by Dr. Robert Lafrenie (Health Science North
Research Institution, Sudbury, Canada). THP-1 is characterized as a large rounded single
nonadherent cell. It is a phagocytic cell that can be differentiated into macrophage cells using
phorbol 12-myristate 13-acetate (PMA) (Tsuchiya et al, 1980). THP-1 cells were cultured as
described by Walev et al, (2001) with some modification. In brief, culturing of the cells were
conducted in Corning® T-75 flasks in GI-1640 Medium [Hyclone] with 10% Fetal Calf Serum
(FCS) [Hyclone], and 1X 100 µg/ml streptomycin and 100 unit/ml penicillin [Life Technologies]
at 37°C and 5% CO2. The cells were cultured by the addition of a fresh media every 2 or 3 days.
The viability of the cell was constantly checked by microscopy check using Trypan Blue stain [Bio
rad] and to ensure the concentration of the cell remains below 1x106 cell/ml. Pores were formed
in the plasma membrane of the THP-1 cells using 20 ng/ml Streptolysin-O (SLO) [Sigma] and 200
µl of ~9x106 THP-1 cell/sample in the presence of 50 µg/ml Fluorescein Isothiocyanate
Conjugated (FITC)-albumin [Sigma]. This procedure was performed in several steps. The first step
involved the activation of SLO through the incubation of a 1 µl SLO from 1 mg/ml stock in
activation buffer (20 mM/l 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 20
mM/L DTT, and 1X PBS up to 1 ml) at 37°C for 10 min. The second step involved the preparation
of the cell suspension. In this step, 160 ml of 1x106 per ml THP-1 cell culture were centrifuged at
22°C and 400 xg for 10 min and the resulting pellets washed two times with serum free GI media
followed by resuspension of the pellets in about 3 ml of serum free GI media. In the final step, the
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cell suspension and the activated SLO were mixed in the presence of different concentrations of
MmcO. The cells (9x106 cells/200 µl) were divided into 2 sets of 7 tubes: five of the tubes
contained 1 µl of 20 ng/ml SLO, 1 µl 50 µg/ml FITC-albumin, and MmcO concentrations of 0,10
ng, 100 ng, 250 ng, and 500 ng; one tube contained 1 µl 50 µg/ml FITC-albumin and 500 ng
MmcO (without SLO); and one tube contained 1 µl 50 µg/ml FITC-albumin only. Then the
samples were incubated at 37°C for 15 min. After the formation and the permeabilization in the
presence of MmcO, the pores were sealed by treating the cell pellets with ice cold RPMI media
supplemented with 10% FCS, 1 X of 100 µg/ml streptomycin and 100 unit/ml penicillin in addition
to 2 mM CaCl2. The samples were then incubated at 37°C for a further 1 h. As a confirmation of
the occurrence of the permeabilization and resealing of the cells, 5 µl of each sample were
examined using confocal microscopy to demonstrate the FITC-BSA was present in the cell
cytoplasm. Finally, the samples for each set were pelleted and suspended in 200 µl of serum free
RPMI media.
Measurement of Reactive Oxygen Species (ROS)
The ROS assay was carried out using ROS-Glo™ H2O2 Assay kit [Promega]. This assay
is based on measuring the amount of hydrogen peroxide (H2O2) produced after treatment with a
ROS inducer using a H2O2 substrate. The reaction between H2O2 and its substrate result in the
production of Luciferin which generated a light signal in the presence of recombinant luciferase
(Figure 7). A microfluor®1 96-well white plates was used in the performance of the ROS assay
which was done in duplicate in a volume of 100 µl. This assay was performed as described in the
manufacturer’s instructions supplied with the kit. In brief, 80 µl each of the individual 14 samples
was transferred each well of a 96-well white plates containing 20 µl H2O2 substrate. A separate
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set of wells also contained 1 µl 50 ng/ml phorbol 12-myristate 13-acetate (PMA) as the ROS
inducer. The plate was then incubated at 37°C for 30 min followed by treatment with a detection
buffer at RT for 20 min. The measurement of the ROS production was carried out using a Synergy
H4 Hybrid Reader Luminescence reader for 5 s per well.
Statistical analysis
The statistical analysis for the measurement of ROS production (permeabilized/non
permeabilized and induced/uninduced cells) was carried out using one-way ANOVA software
[http://turner.faculty.swau.edu/mathematics/math241/materials/anova/]. The raw data of ROS
concentration for three independent experiments performed in duplicate were uploaded on one-
way ANOVA. Tukey’s software [http://faculty.vassar.edu/lowry/hsd.html] was then used to
determine the actual differences between the MmcO concentrations. All data uploaded are the
mean ± standard error.
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Figure 7: Principle of the ROS sssay: H2O2 converts the supplied H2O2 substrate to a
luciferin precursor, which is then converted to luciferin before the addition of a second
reagent containing recombinant luciferase and D-Cysteine. Finally, the presence of
recombinant luciferase converts the luciferin into a luminescent product. This Figure is
adapted from ROS-Glo™ H2O2 Assay kit (Promega Corp.).
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Results
Cloning and expression of MmcO
Based on the obtained information from Tuberculist 2.6 and NCBI databases, the M.
tuberculosis Rv0846c gene is identified as a probable oxidase or oxidoreductase protein and
recently it has been confirmed as a membrane associated multi-copper oxidase (MmcO) according
to Rowland and Niederweis (2013). MmcO contains 504 amino acids (1515 bp) and a molecular
weight of approximately 54 kDa in its mature form (signal peptide cleaved). For the purpose of
this study, the expressed MmcO had a 9 amino acids linker and a 6x His tag added at the C-
terminus which increased the molecular weight to ~61 kDa (signal peptide unprocessed in E. coli
during expression).
MmcO is functionally characterized for its oxidoreductase activity and the catalytic site
has been located to cysteine 486 which is essential for MmcO activity (Rowland and Niederweis,
2013). MmcO contains two cysteines, the second at position 35 anchors the protein to the
membrane via lipidation (McDonough et al., 2008). The signal sequence at the N-terminus of the
protein is in fact a Tat signal sequence, implying processing through the Tat translocon in the
cytoplasmic membrane instead of the Sec translocon (McDonough et al., 2008). The signal
sequence is 34 amino acids long ending with LAA cleavage site (Figure 8). The cysteine
immediately following the cleavage site is the cysteine most likely modified with lipidation to
anchor the protein to the membrane.
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SPase Cleavage site
Figure 8: MmcO amino acid sequence: underlined is the Tat signal sequence ending with
the LAA cleavage site at amino acid 34 (arrow). The cysteine proposed to be the site of
lipidation is highlighted in red at position 35.
MPELATSGNAFDKRRFSRRGFLGAGIASGFALAACASKPTASGAAGMTAAIDAAEAARPH
SGRTVTATLTPQPARIDLGGPIVSTLTYGNTIPGPLIRATVGDEIVVSVTNRLGDPTSVH
WHGIALRNDMDGTEPATANIGPGGDFTYRFSVPDPGTYWAHPHVGLQGDHGLYLPVVVDD
PTEPGHYDAEWIIILDDWTDGIGKSPQQLYGELTDPNKPTMQNTTGMPEGEGVDSNLLGG
DGGDIAYPYYLINGRIPVAATSFKAKPGQRIRIRIINSAADTAFRIALAGHSMTVTHTDG
YPVIPTEVDALLIGMAERYDVMVTAAGGVFPLVALAEGKNALARALLSTGAGSPPDPQFR
PDELNWRVGTVEMFTAATTANLGRPEPTHDLPVTLGGTMAKYDWTINGEPYSTTNPLHVR
LGQRPTLMFDNTTMMYHPIHLHGHTFQMIKADGSPGARKDTVIVLPKQKMRAVLVADNPG
VWVMHCHNNYHQVAGMATRLDYIL
35
The rv0846c gene was amplified from M. tuberculosis H37Rv genomic DNA using PCR.
The successful amplification involved the use of an optimal annealing temperature of 62°C. A
single band with an appropriate size of 1557 bp, which corresponds to the predicted size of rv0846c
gene, was resolved on a 1% agarose gels supporting the efficient amplification of rv0846c (Figure
9). The PCR product could be demonstrated as fragments by cutting the recombinant plasmid with
NdeI and NotI which appeared as double bands, a band at ~1600 bp (the insert) and the another
one around the ~5500bp (host plasmid) which were visualized on 1% agarose gels (Figure 10).
These fragments determined the successful cloning.
Protein Extraction and Purification
Localization of the expressed MmcO
Determination of the cellular localization of expressed MmcO is the most important step.
Different extracts from different subcellular compartments including cytoplasmic, periplasmic,
and inclusion bodies were isolated and separated on 10% SDS-PAGE gel and subjected to western
blot analysis versus a negative control (the untransfected host cell BL21). The Figure 11A shows
that the MmcO expected band was found to be at ~61 kDa; however, this band was only present
in the pellet of an inclusion bodies extracted with 4% SDS. The western blot showed anti His-tag,
(anti His-tag combined to anti-rabbit IgG alkaline phosphates conjugated antibody), reactive band
at 61 kDa corresponding to MmcO size (Figure 11B PVDF membrane). Thus, we decided to
extract the MmcO protein from the inclusion bodies. However, using SDS to extract the MmcO
protein was ineffective because SDS inhibits MmcO activity (More et al, 2011). In addition,
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M MRv0846c gene
Figure 9: rv0846c gene product from the PCR. The arrows on 1%
agarose gel indicate the actual size of Rv0846c gene product at 1557
bp after the PCR, M=marker
Figure 10: Double digestion after cloning. 1% agarose gel shows in line (1) a
double digestion of the construct that results in two bands, insert and empty pET21a
plasmid. M=marker.
Vector
Insert
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Figure 11: Localization of expressed MmcO in three cell fractions: (A) 10% SDS-PAGE gel
stained by Coomassie stain represents the extraction of recombinant MmcO from periplasmic
(suc/sh) fraction, cytoplasmic (wc) fraction and inclusion bodies (pellet) fraction. These fractions
were compared to the empty E.coli BL21 (host).The gel shows that MmcO was expressed and
extracted successfully from pellet at the right size of 61 kDa. (B) Both 10% SDS-PAGE gel stained
by Coomassie stain and western blot for anti-6xHis tag, show the expected band at 61 kDa and
(B)
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potential contamination of MmcO’s extract with host cell’ endogenous proteins could be
problematic (Figure 11B SDS-PAGE gel). Therefore, the inclusion bodies extraction protocols
were optimized and modified for higher efficiency.
Extraction of MmcO from inclusion bodies
Several attempts to purify soluble and active MmcO from the BL21 expression host have
failed. Expression of MmcO in the E. coli BL21 strain under the T7 promoter resulted in the
formation of inclusion bodies, which are an insoluble form of protein, despite the presence of a
MmcO signal peptide. In fact, inclusion body extraction methods were used to obtain sufficient
and pure protein extracts. To obtain an active MmcO protein, the denaturant urea was used, then
gradually removed using dialysis against a buffered solution containing no urea. Based on the
previous experiments that were conducted in our laboratory, refolding insoluble proteins in salt
buffer reduced the formation of aggregates during the refolding period. As the refolding of MmcO
in 10 mM Tris-HCl buffer pH 7.4 was completed, the expected band was visualized via
electrophoresis on 10% SDS-PAGE gels and Western blot analysis on PVDF membranes (Figure
12 PC). The gel illustrates double bands (Figure 12 PC); the expected band at the size of 61 kDa
and another one at ~130 kDa. However, the PVDF membrane shows only the targeted band (61
kDa) after detection with the anti-His antibody. This result indicates that the single band on the
PVDF membrane, which is the actual size of the recombinant MmcO protein, as well as confirms
the effective extraction of MmcO protein from the inclusion bodies.
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Purification of the MmcO
Although inclusion body extraction resulted in almost purified MmcO protein, absolute
purification required addition steps. Therefore, the refolded MmcO sample was subjected to
chromatograph on 1ml affinity Nickel column to purify the His-tagged MmcO protein. The affinity
purified MmcO protein was detected as a single band at 61 kDa following 10% SDS-PAGE and
western blot analysis using anti His-tag antibody (Figure 12, P-MmcO). The flow through fraction
was also examined for additional confirmation, which appeared to contain two bands on 10% SDS-
Page gel but a single band at 61 kDa by western blot analysis (Figure 12, FT). This indicates the
expected band size of MmcO protein but also a contaminating protein. Following affinity
purification on nickel-agarose, a single band at about 61 kDa was obtained on gels and western
blot membranes. Thus, the above results indicated the successful extraction and purification of
MmcO protein.
MmcO activity measurement
The activity of purified MmcO protein was characterised using a widely known oxidation
substrate called ABTS. In this experiment, ABTS was oxidised by active MmcO and resulted in a
green color. The oxidation of ABTS in 200 µl total reaction volume was measured at 405 nm. The
activity of 20 µg MmcO was determined by calculating the MmcO in nmol/min.mg specific
activity every 30 min. The greatest activity 47 nmol/min.mg determined after the first 30 min of
the incubation period. After one hour, the activity dropped sharply by a half then continued to
decrease over 3 h. The last recorded reading indicates less than 10 nmol/min.mg as the graph
shown (Figure 13). This result indicates that the MmcO protein is active and that its greatest
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Figure 12: Purification of MmcO extracted from inclusion bodies: (A) 10% SDS-PAGE gel stained by
Coomassie stain shows the purified MmcO (P-MmcO) fraction, Flow through (FT) fraction, Pre-column
refolded (PC) fraction and those fractions were compared to the empty E.coli BL21 cell lysate (lane C).
These fractions were run in 40 µg total protein concentration. MmcO was purified successfully and the
expected band appears at the right size of 61 kDa. (B) western blot using anti-6xHis tag antibodies. The
blot confirms the result from the SDS-PAGE gel. M=Marker
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Figure 13: Specific activity of purified MmcO using ABTS substrate: The graph represents
the specific activity of purified MmcO over the time using ABTS substrate. The experiment was
carried out in triplicates and the values given are the average. Bars represent the mean ± standard
error. The high activity of MmcO is detected in the first 30 min of incubation time (47
nmol/min.mg) followed by a gradually decrease for the rest of 3 h.
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activity occurs at a period of 30 min of the reaction and also that the MmcO protein loses activity
over time.
Delivering MmcO into THP-1 cells
Determination of the effect of the MmcO protein on ROS production was carried out in the
THP-1 monocyte cell line. This cell line has been utilized previously by several groups to study
ROS production effect in monocyte/macrophages as well as in response to immunological
activities (Chanputa et al, 2014). In this study, 200 µl of THP-1 (~9x106 cell/sample) cells were
SLO-permeabilized in the presence of serial concentrations (0 ng, 10 ng, 100 ng, 250 ng, 500 ng)
of MmcO protein along with FITC-albumin. Confirmation of successful delivery of MmcO protein
in the cells was observed using the FITC-albumin labelling of cells by confocal microscopy
(Figure 14). Cells were shown to contain the FITC labelling supporting the idea that proteins in
the labelling media were able to enter and become trapped inside the cell using SLO
permeabilization method. However, when visualising the fluorescent signals in non-permeabilized
cells using confocal microscopy only cell fragments were found to bind label, while the intact cells
remained unlabelled (Figure 15). This observation proved that SLO is the permeabilization tool.
To confirm a successful MmcO delivery to the cells, the cytoplasmic extract of permeabilized cells
was run on 10% SDS-PAGE gel and transferred to a PVDF membrane for western blot analysis.
The gel shows THP-1 cells unspecific band from the cell’s extract whereas the western blot
confirms the presence of MmcO protein (61 kDa) at the 500 ng MmcO lane after the treatment
with anti-6xHis tag antibody (Figure 16). Cell viability assessments were routinely carried out
using trypan blue exclusion (data not shown).
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Figure 14: Confocal microscopy images of permeabilized THP-1 cells teated with MmcO: (A)
The arrows indicate the THP-1 viable cell shape. (B) Green color represents the permeabilized cells
with FITC-Albumin after resealing the membranes. (C) This panel shows the combined images of
panels A&B to confirm the green fluorescent light is present inside the cells and not from the
background.
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Figure 15: Confocal microscopy images of non-permeabilized THP-1 cells treated with MmcO:
(A) The arrows indicate the THP-1 viable cell shape. (B) Fluorescent imaging of the same cells as in
panel A. The cells do not display any fluorescence. (C) Combined image of panels A&B to confirm
that the green fluorescence in panel B does not originate from the cells.
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Figure 16: Confirmation of permeabilization of THP-1 cells treated with MmcO: (A) 10% SDS-
PAGE gel stained by Coomassie stain represents cytoplasmic extract of the THP-1 cell permeabilized
with 250 ng MmcO (PC 250 ng MmcO) fraction and cytoplasmic extract of the THP-1 cell
permeabilized with 500 ng MmcO (PC 500 ng MmcO) fraction. These fractions were compared to the
empty THP-1 cell extract (lane C). (B) western blot for anti-his, confirms that MmcO was successfully
permeabilized in the THP-1 cells using SLO and the expected band appears at 61 kDa. M=Marker
A B
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Measurement of reactive oxygen species (ROS)
The ROS assay is the last step to determine the effect of an active MmcO protein on the
production of ROS. PMA inducer is commercially characterised as an inducer to promote the
production of ROS. Thus, optimising the incubation time after inducing the cells with/without
PMA in the presence of different MmcO protein concentrations was very important factor in this
experiment. The ROS readings were conducted after 15 min and 30 min of incubation. The result
shows that the highest ROS production was measured at 30 min incubation period. Based on this
result, the ROS assay was incubated for 30 min before the detection stage (Figure 17). Longer time
periods were also investigated but activity of MmcO was seen to decrease beyond 30 minutes (data
not shown).
After the induction with PMA, the results of the ROS assay on the permeabilized cells were
compared to the 0ng MmcO condition for each experiment, which was used as the negative control
(Figure 18). The graph illustrates that ROS productions did not show any significant affects at
certain level of MmcO (between 10 ng and 100 ng) in induced cells, whereas 250 ng of MmcO
sample showed a slight increasing by 10.9%. However, the comparison between the control (0 ng)
and 500ng concentrations of MmcO showed an obvious decrease in the ROS production by almost
14.1 %. Statistically, the concentrations (10 ng, 100 ng, and 250 ng) of MmcO protein did not
show any statistical differences relative to the control, whereas the highest concentration (500 ng)
of MmcO showed a statistical difference with p value < 0.05 to the control (Figure 18 A). The
uninduced-permeabilized cells did not illustrate any ROS production differences (Figure 18 B).
Moreover, the calculated ratio between induced and uninduced reactions indicated the same
general results (Figure 19). In the presence of 500 ng MmcO, the ROS was reduced by 32.1% in
the permeabilized THP-1 cell (Figure 19). Furthermore, testing the effect of MmcO protein outside
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the cells by treating non-permeabilized induced cells with 500 ng MmcO protein showed a 19.9%
decrease in the ROS production compared to the control (Figure 20 A). Statistically, the
concentrations 500ng of MmcO protein showed a statistical difference with p value < 0.01 to the
control. The bar graph (Figure 20 B) illustrates that there was no significant difference between
results of ROS production in uninduced cells that were either exposed to MmcO or not.
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Figure 17: Optimizing the Incubation Time for the ROS Reduction by MmcO: The graphs
show the average amount of ROS production in the presence of different MmcO protein
concentrations, after the induction with/without PMA inducer in (15min and 30min). (A)
permeabilized and induced samples, (B) permeabilised and uninduced samples. However, (C) non-
delivered and induced samples, and (D) non- delivered and uninduced samples. Generally, the
highest level of ROS production is presented differently between the various concentrations of
MmcO after 30min of induction compared to 15min.
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Figure 18: ROS production in permeabilized THP-1 cells treated with MmcO: The graphs
illustrate the average amount of ROS production in the presence of different MmcO protein
concentrations (10 ng, 100 ng, 250 ng, 500 ng) after the induction (A) with PMA inducer and (B)
without PMA induction. The values are represented in both graphs as mean of three individual
experiments carried out in duplicate. Bars represent the mean ± standard error. In the induced
samples (A), the ROS production show a significant decrease in the production of ROS at 500 ng of
MmcO comparing to 0 ng. * indicates a statistical difference in induced sample relatively to the 0ng
with p<0.05. However, (B) graph does not show any ROS production differences comparing to the
control.
*
*
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Figure 19: ROS ratio between induced and uninduced THP-1 cells with MmcO: the ratio of
the ROS production represented in this graph in the different concentration of MmcO and bars
indicate the mean ± standard error. From the data, there is a decrease of ROS level at 500ng of
MmcO. This indicates the greatest reduction affect in the ROS production level. * indicates a
statistical difference relatively to the 0ng with p<0.05.
*
*
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Figure 20: ROS generation in non-permeabilized THP-1 cells with MmcO: The graphs represent
the average amount of ROS production in the presence of 500 ng MmcO protein concentration after
the induction (A) with PMA and without PMA (B) induction. The values are represented in both graphs
as mean of three individual experiments carried out in duplicate. Bars represent the mean ± standard
error. (A) In induced samples, ROS production shows a significant decrease at 500 ng compared to
the control (0 ng). * indicates a significant statistical difference in samples relatively to the 0ng with
p<0.01. However, (B) graph does not show any ROS production differences compared to the control.
*
*
52
Discussion
Mycobacterium tuberculosis is an intracellular pathogenic bacterium that arrests the
respiratory burst process during phagocytosis. M. tuberculosis’ pathogenicity is derived from its
possession of several putative virulence factors that contribute to inhibition of ROS production
and phagocytosis maturation while allows it to survive in the macrophage. In this study, we
investigated the impact of multi-copper oxidase (MmcO), coded by the M. tuberculosis’s Rv0846c
gene, on the production of ROS in living monocytic cells. It is known that ROS are produced in
cells during phagocytosis, where they serve as a shield to protect the host from microbial attack.
Several studies have shown that M. tuberculosis can prevent ROS mediated damage by secreting
superoxide dismutase (SodC and SodA) and catalase-peroxidase (KatG) (Liao et al, 2013; Mo et
al, 2004). These secreted enzymes are characterized by their oxidative activity and since M.
tuberculosis multi-copper oxidase (MmcO) also catalyzes oxidoreductase activities, MmcO may
also prevent ROS mediated damaged.
The main focus of our study is to clone, express, purify and test the contribution of active
MmcO protein towards the protection of the pathogen from ROS molecules. This was done by
delivering different concentrations of a purified and active MmcO protein into living THP-1 cells
by utilizing Streptolysin O as a penetration tool. The THP-1 cell line can produce ROS in response
to stimulation and is suitable to understand the role of MmcO during the respiratory burst process.
Cloning and Expression of the Mycobacterium tuberculosis rv0846c gene
Over decades, E. coli has been an effective host to produce recombinant proteins. The
combination of its fast growth and its well-studied genetics makes E. coli the most suitable host
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for high expression of the target recombinant protein, often producing milligram quanitites of
recombinant proteins per liter (Baneyx, 1999; Rosano & Ceccarelli, 2014). The yield of the over-
expressed protein may be on average of 30%-40% of total intracellular protein expression
(Georgiou & Valax, 1996; Suzuki et al, 2006).
The cloning and expression of the rv0846c gene into the pMAL vector was first conducted
in our laboratory by Johanna Delongchamp. In brief, the synthesized rv0846c gene from the M.
tuberculosis H37Rv genome was obtained from GenScript in a pJET 1.2 vector. It was sub-cloned
into the pMAL c5x/p5x expression vectors, and expressed in an E. coli NEB expression host.
While the cloning was successful, the expression of the gene eventually failed. There are several
possible reasons for this failure; first, pMAL harbours a cleavable maltose binding protein (MBP)
sequence that tags proteins upstream the gene which allows tag cleavage after protein purification.
However, N-terminal labeling was generally avoided because it may disrupt the structure of
Rv0846c and interfere with MmcO protein expression. The other reason for failure appeared to be
the purification failure using the amylose column; although an overexpressed protein at 96kDa,
consisted with the combination of MBP (~43 kDa) and the MmcO (~54 kDa), was obtained. This
led us to investigate the cloning design that was used to clone the rv0846c gene. This showed that
the two genes were cloned with no linker which may promote improper or misfolding of the MBP
binding site and lead to purification failure. The final reason for the failure could be that the
misfolding of the expressed protein affected its secondary and tertiary protein structure, which
disrupted the cleaving site between the MBP and MmcO and resulted in failure of Factor-X
digestion to cleave the site.
To avert the challenges encountered in past experiments, the rv0846c gene was cloned into
the pET21a expression vector that contains the His affinity tag, and transformed it into the E. coli
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BL21 expression host. Additionally, cloning proteins of interest into a plasmid with an affinity tag
facilitates the detection and purification of the recombinant proteins (Rosano & Ceccarelli, 2014).
We designed primers with the addition of 9 amino acids to code for a linker between the 6x-His
tag and the rv0846c gene to limit misfolding and keep the His-tag separated from the mature
protein structure to ensure exposure of the tag for purification.
Heterologous production and purification of MmcO from inclusion bodies
In many instances when the recombinant protein is expressed in a heterologous host,
protein degradation, a low expression level, aggregation of proteins, or insolubility may result
(Georgiou & Valax, 1996). On the other hand, a high level or over-expression of recombinant
protein in the host cell, together with the lack of an adequate amount of chaperones, and high
concentration of folding intermediates, can result in the formation of insoluble structures called
inclusion bodies (Palmer & Wingfield, 2004). The aggregated proteins of the inclusion bodies are
biologically inactive although they can be up to 40-90% pure for a single protein and offer
protection from proteases (Georgiou & Valax, 1996). The predicted localization of the expressed
MmcO protein was in the periplasmic space but tethered to the cytoplasmic membrane by
lipidation of cysteine at position 35. However, protein electrophoresis and western blot analysis
(See Figure 11A, B) did not show a distinct band at ~61kDa in the two periplasmic or cytoplasmic
fractions. Instead, a high-intensity band of about ~61kDa in size, in the insoluble fraction
(inclusion bodies) was obtained (Figure 11A). This result confirmed previous studies by Rowland
and Niederweis (2013) who showed that MmcO protein expressed in E. coli BL21 and was
presented in inclusion bodies. Several strategies by the authors, including various fusions, to
express a properly folded and functional MmcO were unsuccessful. This result was confirmed by
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western blot analysis of all fractions (except WC fraction) with an anti-6xHis antibodies (See
Figure 11 B “SDS-PAGE”). The targeted band at ~61 kDa was present in the blot which suggested
the MmcO protein is in fact insoluble but was successfully expressed. Over expression resulted in
inclusion bodies regardless of the presence of the MmcO signal peptide (See Figure 11 B “PVDF
membrane”).
The MmcO protein was extracted from inclusion bodies using the method of Rudolph &
Lilie (1996) with some modifications. The idea was to obtain functional MmcO by refolding of
the denatured protein. However, in vitro, this approach may result in polypeptide misfolding and
aggregation (Tsumoto et al, 2003). To overcome this, urea was gradually reduced to a low
concentration by step-wise dialysis. This resulted in successful and proper MmcO protein folding
(Figure 12 A PC). The refolded MmcO was a large majority of the aggregated protein and was
relatively pure as demonstrated on 10% SDS-PAGE which showed double bands; one of them was
at the right size for MmcO protein (61kDa). In order to get a highly purified MmcO protein, nickel
affinity chromatography was used. The purification process was done in two stages. In the first
stage, the refolding buffer was exchanged with a conditioning buffer that contains a low
concentration of imidazole (20mM). The conditioning buffer was used to keep MmcO in a buffer
compatible with the nickel affinity resin, and to increase the affinity of the His-tag for the nickel
resin and minimize nonselective binding of host proteins. The SDS-PAGE results showed a single
band which suggests the elution was not contaminated with a significant amount of non-specific
proteins (Figure 12A P-MmcO). The purified MmcO protein could be resolved on SDS-PAGE as
a single band at about 61kDa and the PVDF membrane confirmed presence of the His tag
(Figure12 A&B P-MmcO).
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Enzyme activity of MmcO
The substrate 2,2-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid), or ABTS, was used
to characterize the enzymatic activity of the purified MmcO protein. When the purified MmcO
enzyme was combined with the ABTS, the reaction produced a soluble green-colored product.
Contrary to a recent study that maintained a 5-minute monitoring of the MmcO activity (Rowland
& Niederweis, 2013), we found that a 5-minute incubation time is insufficient. Monitoring the
absorbance for the color change of ABTS every 30 min for four hours revealed that after the first
30 minutes, a 20 µg (0.33nmol) sample of the MmcO had a consistent high activity translating to
about 47 nmol/min.mg protein. During the following intervals, there was a gradual decrease such
that at the fourth hour mark, there was less than 10 nmol/min.mg (See Figure 13). This level of
specific activity translates to 235 μM·min-1·mg-1. This is considered substantial activity
considering that lysates of wild type M. tuberculosis show activities towards ABTS in the range
of 2 μM·min1·mg1 (Rowland and Niederweis, 2013). Although the gels and the western blots in
this study show a single band for the purified MmcO such data does not exclude the presence of
denatured protein in the samples. Further analysis using analytical gel permeation or sedimentation
experiments will need to be crried out to establish how much of the purified and refolded protein
is in fact properly folded.
M. tuberculosis’ MmcO may potentially suppress the production of ROS
Reactive Oxygen Species (ROS) for example, superoxide, oxygen ion, and H2O2, are
extremely reactive molecules (Newsholme et al, 2012). They are continuously produced in the
process of macrophage phagocytosis as a macrophage antibacterial method. However, when they
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produced in excess amounts, they can lead to oxidation of proteins and DNA, in addition to cross-
liking proteins and degrade pathogenic bacteria (Uy, McGlashan, & Shaikh, 2011).
To address the last aim of this study, it was important for us to study the impact of MmcO
on ROS generated within cells (Uy, McGlashan & Shaikh, 2011). THP-1 cells, a human monocyte
leukemia cell line (Adati et al, 2009), were used to investigate ROS production and effects of
MmcO thereon. Purified MmcO was added to the THP-1 cells using Streptolysin O to facilitate
membrane permeability following the Walev et al. (2010) protocol. THP-1 cells were chosen
because it is one of macrophage lineages (Uy, McGlashan, & Shaikh, 2011) and can generate ROS
to model the production of ROS by monocyte/macrophages during their immune pathway response
(Chanputa et al, 2014). The THP-1 cells were treated with Phorbol 12-myristate 13-acetate (PMA)
to promote the ROS production (Uy, McGlashan, & Shaikh, 2011).
In vitro, hydrogen peroxide (H2O2) produced by the THP-1 cell line is a useful read out of
the ROS (Newsholme et al, 2012). H2O2 has a longer life in solution and can easily diffuse from
the cell, thus proving to be an excellent oxidation stress marker (Duellman et al, 2013). In order to
test the theory that MmcO protein can reduce the amount of ROS, we measured the H2O2 produced
by THP-1 cells, treated with MmcO and afterword with PMA. First, Optimizing the incubation
duration was very important factor in this experiment. Thus, we carried the optimization
experiment up with an interval of 15 and 30 minutes to enable us to optimize the time of the
reaction. It is evident that MmcO showed its activity against ROS after 30 minutes period of the
reaction, which was also compatible with the highest MmcO activity read against ABTS (See
Figure 17). Based on this result, the ROS-Glo Assay kit was incubated for about 30 minutes on
the permeabilized THP-1 cells that were treated with several concentrations of the MmcO protein
(10 ng, 100 ng, 250 ng, 500 ng) and compered to the control (0 ng of MmcO). It was said that
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several ROS are usually converted to H2O2 in a cell and because H2O2 half-life is long enough, any
increase in the H2O2 shows a relative increase in the levels of ROS. The chemical pathway for
ROS-Glo assay was started by using a H2O2 substrate that directly reacted with H2O2 to produce
Luciferin precursor, which was not an appropriate substrate for use by luciferase. By adding the
ROS-Glo Detection Solution, the precursor was converted to luciferin, which made it possible for
luciferase and other compounds to be able to produce light signals that were equivalent to the
present H2O2 levels (See Figure 7) (Duellman et al, 2013).
Interestingly, we found that when we exposed the induced/uninduced THP-1 cells to the
500 ng purified MmcO, the levels of ROS were reduced. On the other hand, ROS production did
not indicate a significant increased when treated with 10ng and 100ng of MmcO, but there was a
slight increase in ROS production at 250ng of MmcO (Figure 18 A). However, this increase did
not indicate any statistical difference comparing to the control. The 500ng showed an obvious
statistical difference with p value < 0.05 relatively to the control; therefore, we hypothesised that
the reduction of ROS levels in the presence of higher level of MmcO (500ng) could be due to
several reasons. First, the 500ng of MmcO protein may have contained just the right fraction of
active enzyme to effect further ROS production. Second, since ROS being inducible in the
experiment, its production would be less likely to be affected from the low MmcO protein
concentration whereas 500 ng of MmcO protein was enough to show an effective detectable shift
on the ROS production because the enzyme needed to be active during the experiment. Finally,
any level of MmcO, when used intracellularly, may have shorter half-life where intracellular
factors including proteases may have made it impossible for the low levels of MmcO to cause a
detectable reduction in ROS levels. However, the assay mechanism is based on measuring all the
ROS production in the reaction volume (in- and outside the cell). Therefore, the slight increase of
59
the ROS production at 250 ng of MmcO might be a result of the outside ROS measurement, since
ROS such as H2O2 can be easily defused across the cytoplasmic membrane to outside the cell when
MmcO was restricted to the ROS inside the cell. Another theory could be some undetectable E.
coli proteins residual accompanied MmcO during the purification, enhanced the production of
ROS along with PMA inducer. Our calculations of the ROS concentration ratio between the
induced/uninduced cells confirmed that the effect of 500 ng MmcO protein was to reduce the ROS
concentration by 32.1 % as compared to other concentrations (Figure 19). Additionally, the impact
of 500 ng MmcO protein on extracellular ROS production was tested and shown to be very
efficient and statistically difference with p value < 0.01 relatively to the control (Figure 20 A). The
most likely reason for this observation is that MmcO could be used as scavenger outside cells by
interfering with the ROS molecules production through reduction of levels of available oxygen.
Since the MmcO is from the same family as the Laccases, it is possible that it may have similar
impacts on oxidizing host substances to produce scavengers of reactive species and maintain a
reducing environment for pathogens (Zhu et al, 2001). Nevertheless, extracellular laccases, if
present, reduce free ions in the macrophage and prevents respiratory burst responses (Zhu et al,
2001). Our experiments showed unanticipated results where the uninduced and non-permeabilized
THP-1 cells showed a high level of ROS production even though they were not exposed to PMA
inducer (Figure 20 B). A possible explanation for this outcome would be that even though ROS
production is PMA controlled, there is always some ROS production by any environmental
substances including LPS, or the natural ROS production from the cell’s organelles. Collectively,
these may have contributed heavily to the observed levels of ROS. Additionally, treatment of the
cell with SLO and permeabilization of the membrane may render the cells more sensitive or
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responsive to environmental stress than non-permeabilized cells. Conversely, treated cells may
experience disturbance in their ability to respond effectively to environmental stimuli.
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Conclusion
The main goal of this study was to explore a possible role for a purified and active M.
tuberculosis rv0846c gene product, MmcO, in interfering with ROS production in model
macrophages. The MmcO protein was extracted from inclusion bodies and refolded into an active
form. To date, it is the first report of functional recombinant MmcO. Recombinant MmcO
suppressed ROS levels in THP-1 cells. This effect was observed when the MmcO protein was
delivered inside THP-1 cells via membrane permeabilization with Streptolysin O or when used
outside the cells.
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Appendix
The Rv0846c amino acid Sequence from M. tuberculosis H37Rv using
TubercuList:
Gene name: Rv0846c.
Function: May have multicopper oxidase activity.
Product: Probable oxidase.
Protein MW: 53795.9 Da.
Protein length: 504 aa.
Amino acid composition: A54 C2 D33 E16 F13 G55 H18 I28 K12 L38 M17 N19 P41 Q11 R26
S19 T47 V32 W7 Y16.
MPELATSGNA FDKRRFSRRG FLGAGIASGF ALAACASKPT ASGAAGMTAA
IDAAEAARP SGRTVTATLT PQPARIDLGG PIVSTLTYGN TIPGPLIRAT VGDEIVVSVT
NRLGDPTSVH WHGIALRNDM DGTEPATANI GPGGDFTYRF SVPDPGTYWA
HPHVGLQGDH GLYLPVVVDD PTEPGHYDAE WIIILDDWTD GIGKSPQQLY
GELTDPNKPT MQNTTGMPEG EGVDSNLLGG DGGDIAYPYY LINGRIPVAA
TSFKAKPGQR IRIRIINSAA DTAFRIALAG HSMTVTHTDG YPVIPTEVDA
LLIGMAERYD VMVTAAGGVF PLVALAEGKN ALARALLSTG AGSPPDPQFR
PDELNWRVGT VEMFTAATTA NLGRPEPTHD LPVTLGGTMA KYDWTINGEP
YSTTNPLHVR LGQRPTLMFD NTTMMYHPIH LHGHTFQMIK ADGSPGARKD
TVIVLPKQKM RAVLVADNPG VWVMHCHNNY HQVAGMATRL DYIL.
